, and bones, and it�s not clear how the drugs will affect them after long-term use.
.
.
.
.
.
.
�we have waited a long time and we cannot possibly wait any longer,� karmenu vella, european commissioner for environment, told the guardian.
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
walter reed national military medical center in bethesda, maryland, would not give any details about why the first lady was still there.
.
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.